Why should you sell the products in the Critical Advantage Portfolio to your clients? The numbers tell the story.
- Nearly 1.7 million new cases of cancer were diagnosed in 2016
- 27.6 million Americans have been diagnosed with heart disease
- Every 40 seconds someone in the U.S. has a stroke
- Nearly 5 million Americans have Alzheimer’s disease
The products in the Critical Advantage Portfolio pay a lump-sum benefit upon diagnosis for all of these conditions and the money is sent directly to your client, not the health care provider.
To learn more about the products in the Critical Advantage Portfolio, click here.
If you have any questions, please contact Mutual of Omaha’s Sales Support at (800) 693-6083 or e-email email@example.com.